Each year we award a $25,000 Sherman Emerging Leader Prize to an IBD clinician, surgeon, researcher, academic, physician assistant, nursing professional, or public health advocate who, while early in his or her career, has contributed to an advancement in his or her discipline and shows great promise for significant contributions in the future. Emerging Leader Prize recipients seek out new roles, challenge the status quo, and pursue experiences that test their leadership skills and support their future aspirations. The Sherman Emerging Leader Prize is open to individuals who have demonstrated excellence in areas such as those listed below.
Nominee provides outstanding and responsive clinical care, and makes strides to improve the physical, emotional and/or psychosocial aspects of treatment:
- Ensuring the highest levels of patient care, improving patients’ social and emotional well-being, and overcoming obstacles to achieve better outcomes for patients.
- Identifying risk factors for Crohn’s disease and ulcerative colitis and improving diagnosis.
- Providing patients with the opportunity to make informed decisions about their care and treatment, as well as comprehensive and culturally appropriate communications tailored to the patient’s needs.
- Providing families and caregivers with information and support.
- Providing outstanding care demonstrating an acumen for the clinical management of compassionate and effective treatment of IBD patients.
Nominee is active in groundbreaking scientific research in pursuit of treatment advances that improve the lives of people with IBD and could lead to prevention, remission and cures:
- Studying risk factors for Crohn’s disease and ulcerative colitis in an effort to improve diagnosis.
- Determining the environmental and/or genetic factors that enhance the risk of Crohn’s and colitis.
- Deepening our understanding of the multiple disease processes under the IBD umbrella.
- Developing tools that will predict the aggressiveness of the disease, whether complications will develop, and how individual patients will respond to particular therapies.
- Studying new medications and treatments that induce remission and prevent relapse.
- Discovering ways to prevent complications.
- Encouraging multidisciplinary research focused on new technologies and systems to treat and cure Crohn’s and colitis.
- Predicting and preventing the onset of these diseases in high-risk individuals.
Public Service, Education and Advocacy
Nominee excels in supporting peers, raising awareness, and advocating for improvements in approaches and policies affecting IBD patients and caregivers:
- Mastering the issues, policies or regulations affecting constituents and advocating successfully for positive improvements on behalf of patients.
- Assisting colleagues and peers in developing meaningful careers in IBD.
- A proven track record for implementing professional networks, organizations or volunteer support groups, or raising significant funds for research and/or communications and awareness.
- Developing communication and education efforts to:
- Inform the public, patients and other professionals of the risk factors for the diseases.
- Raise awareness on the environmental and genetic factors that enhance the risk or progression of the diseases.
- Raise awareness of new medications and treatments that induce remission and prevent relapse of the diseases.
Eligible individuals must live and work in the U.S., having accomplished their greatest achievements in the last few years.
Nominees who aren’t selected can be nominated again in coming years with a new submission that highlights further achievements.